From metabolic normality to cardiometabolic risk factors in subjects with obesity

Obesity

Volumn 20, Issue 10, 2012, Pages 2063-2069

  Bobbioni Harsch, Elisabetta ^a   Pataky, Zoltan ^a   Makoundou, Vincent ^a   Laville, Martine ^b   Disse, Emmanuel ^b   Anderwald, Christian ^c   Konrad, Thomas ^d   Golay, Alain ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Centre de Recherche en Nutrition Humaine Rhne Alpes   (France)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; ECHOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MORBIDITY; OBESITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RISK FACTORS; YOUNG ADULT;

EID: 84866738608     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.69     Document Type: Article

References (27)

1. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011;35:971-981.
2. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond) 2010;34 Suppl 2:S18-S23.
3. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
4. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004;30:569-572.
5. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci C V, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005;13:1116-1122.
6. Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2005;2:105-112.
7. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
8. Arnlöv J, Sundström J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011;34:61-65.
9. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009;32:2297-2299.
10. Arnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010;121:230-236.
11. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
12. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
13. Calori G, Lattuada G, Piemonti L et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-215.
14. Pataky Z, Makoundou V, Nilsson P et al. Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes (Lond) 2011;35:1208-1215.
15. Hills SA, Balkau B, Coppack SW et al.; EGIR-RISC Study Group. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 2004;47:566-570.
16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223.
18. Mercuri M, McPherson DD, Bassiouni H, Glagov S. Non-invasive Imaging of Atherosclerosis. Kluwer, The Netherlands, 1998.
19. Mazzone AM, Urbani M P, Picano E et al. In vivo ultrasonic parametric imaging of carotid atherosclerotic plaque by videodensitometric technique. Angiology 1995;46:663-672.
20. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005;48:1911-1918.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Craig CL, Marshall AL, Sjöström M et al. International physical activity questionnaire:12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
23. Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-S504.
24. Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
25. Shin MJ, Hyun YJ, Kim OY et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006;30:1529-1534.
26. Janiszewski PM, Ross R. The utility of physical activity in the management of global cardiometabolic risk. Obesity (Silver Spring) 2009;17 Suppl 3:S3-S14.
27. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008;51:1752-1754.